521. Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.
作者: Jana Jarosova.;Lea Zarivnijova.;Ivana Cibulkova.;Jan Mares.;Peter Macinga.;Alzbeta Hujova.;Premysl Falt.;Ondrej Urban.;Jan Hajer.;Julius Spicak.;Tomas Hucl.
来源: Gut. 2023年72卷12期2286-2293页
Endoluminal radiofrequency ablation (RFA) has been promoted as palliative treatment for patients with cholangiocarcinoma (CCA) and pancreatic ductal adenocarcinoma (PDAC) in order to improve biliary drainage and eventually prolong survival. No high level evidence is, however, available on this technique.
523. Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing.
Mucosal healing on endoscopy has emerged as a key prognostic parameter in the management of patients with IBD (Crohn's disease, ulcerative colitis/UC) and can predict sustained clinical remission and resection-free survival. The structural basis for this type of mucosal healing is a progressive resolution of intestinal inflammation with associated healing of ulcers and improved epithelial barrier function. However, in some cases with mucosal healing on endoscopy, evidence of histological activity in mucosal biopsies has been observed. Subsequently, in UC, a second, deeper type of mucosal healing, denoted histological healing, was defined which requires the absence of active inflammation in mucosal biopsies. Both levels of mucosal healing should be considered as initial events in the resolution of gut inflammation in IBD rather than as indicators of complete transmural healing. In this review, the effects of anti-inflammatory, biological or immunosuppressive agents as well as small molecules on mucosal healing in clinical studies are highlighted. In addition, we focus on the implications of mucosal healing for clinical management of patients with IBD. Moreover, emerging techniques for the analysis of mucosal healing as well as potentially deeper levels of mucosal healing such as transmural healing and functional barrier healing of the mucosa are discussed. Although none of these new levels of healing indicate a definitive cure of the diseases, they make an important contribution to the assessment of patients' prognosis. The ultimate level of healing in IBD would be a resolution of all aspects of intestinal and extraintestinal inflammation (complete healing).
525. Inflammatory bowel disease in STAT1 gain-of-function immunodeficiency treated with precision medicine.
作者: Julian Schwärzler.;Andreas Zollner.;Theresa Dolejsi.;Lisa Mayr.;Georg Oberhuber.;Johannes Zschocke.;Wolfgang Sturm.;Ivan Tancevski.;Timon Erik Adolph.;Herbert Tilg.
来源: Gut. 2024年73卷8期1394-1396页 526. Gastrointestinal syndromes preceding a diagnosis of Parkinson's disease: testing Braak's hypothesis using a nationwide database for comparison with Alzheimer's disease and cerebrovascular diseases.
作者: Bo Konings.;Luisa Villatoro.;Jef Van den Eynde.;Guillermo Barahona.;Robert Burns.;Megan McKnight.;Ken Hui.;Gayane Yenokyan.;Jan Tack.;Pankaj Jay Pasricha.
来源: Gut. 2023年72卷11期2103-2111页
Braak's hypothesis states that Parkinson's disease (PD) originates in the gastrointestinal (GI) tract, and similar associations have been established for Alzheimer's disease (AD) and cerebrovascular diseases (CVD). We aimed to determine the incidence of GI syndromes and interventions preceding PD compared with negative controls (NCs), AD and CVD.
527. Dietary wheat amylase trypsin inhibitors exacerbate CNS inflammation in experimental multiple sclerosis.
作者: Victor F Zevallos.;Nir Yogev.;Judith Hauptmann.;Alexei Nikolaev.;Geethanjali Pickert.;Valeska Heib.;Nicola Fittler.;Sebastian Steven.;Felix Luessi.;Manjusha Neerukonda.;Claudia Janoschka.;Ann-Marie Tobinski.;Luisa Klotz.;Ari Waisman.;Detlef Schuppan.
来源: Gut. 2023年73卷1期92-104页
Wheat has become a main staple globally. We studied the effect of defined pro-inflammatory dietary proteins, wheat amylase trypsin inhibitors (ATI), activating intestinal myeloid cells via toll-like receptor 4, in experimental autoimmune encephalitis (EAE), a model of multiple sclerosis (MS).
528. Key metabolomic alterations are associated with ulcerative colitis disease state and activity: a validation analysis.
作者: John David Chetwood.;Sudarshan Paramsothy.;Craig Haifer.;Thomas J Borody.;Michael A Kamm.;Rupert W Leong.;Nadeem O Kaakoush.
来源: Gut. 2024年73卷8期1392-1393页 529. APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer.
作者: Yuhua Tian.;Xin Wang.;Zvi Cramer.;Joshua Rhoades.;Katrina N Estep.;Xianghui Ma.;Stephanie Adams-Tzivelekidis.;Bryson W Katona.;F Brad Johnson.;Zhengquan Yu.;M Andres Blanco.;Christopher J Lengner.;Ning Li.
来源: Gut. 2023年72卷12期2294-2306页
Colorectal cancer (CRC) is a leading cause of cancer-related deaths, with the majority of cases initiated by inactivation of the APC tumour suppressor. This results in the constitutive activation of canonical WNT pathway transcriptional effector ß-catenin, along with induction of WNT feedback inhibitors, including the extracellular palmitoleoyl-protein carboxylesterase NOTUM which antagonises WNT-FZD receptor-ligand interactions. Here, we sought to evaluate the effects of NOTUM activity on CRC as a function of driver mutation landscape.
532. Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis.
作者: Shihao Xie.;Jiaxin Li.;Fengyuan Lyu.;Qingming Xiong.;Peng Gu.;Yuqi Chen.;Meiling Chen.;Jingna Bao.;Xianglong Zhang.;Rongjuan Wei.;Youpeng Deng.;Hongzheng Wang.;Zhenhua Zeng.;Zhongqing Chen.;Yongqiang Deng.;Zhuoshi Lian.;Jie Zhao.;Wei Gong.;Ye Chen.;Ke-Xuan Liu.;Yi Duan.;Yong Jiang.;Hong-Wei Zhou.;Peng Chen.
来源: Gut. 2023年73卷1期78-91页
The pathogenesis of sepsis is complex, and the sepsis-induced systemic proinflammatory phase is one of the key drivers of organ failure and consequent mortality. Akkermansia muciniphila (AKK) is recognised as a functional probiotic strain that exerts beneficial effects on the progression of many diseases; however, whether AKK participates in sepsis pathogenesis is still unclear. Here, we evaluated the potential contribution of AKK to lethal sepsis development.
534. British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance.
作者: Antonia Md Churchhouse.;Victoria El Moffat.;Christian P Selinger.;Christopher A Lamb.;Michelle J Thornton.;Ian Penman.;Shahida Din.; .; .
来源: Gut. 2023年72卷9期1631-1634页 537. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
作者: Zhongqi Fan.;Meishan Jin.;Lei Zhang.;Nanya Wang.;Mingyue Li.;Chuanlei Wang.;Feng Wei.;Ping Zhang.;Xiaohong Du.;Xiaodong Sun.;Wei Qiu.;Meng Wang.;Hongbin Wang.;Xiaoju Shi.;Junfeng Ye.;Chao Jiang.;Jianpeng Zhou.;Wengang Chai.;Jun Qi.;Ting Li.;Ruoyan Zhang.;Xingkai Liu.;Bo Huang.;Kaiyuan Chai.;Yannan Cao.;Wentao Mu.;Yu Huang.;Tian Yang.;Huimao Zhang.;Limei Qu.;Yahui Liu.;Guangyi Wang.;Guoyue Lv.
来源: Gut. 2023年72卷11期2149-2163页
Selecting interventions for patients with solitary hepatocellular carcinoma (HCC) remains a challenge. Despite gross classification being proposed as a potential prognostic predictor, its widespread use has been restricted due to inadequate studies with sufficient patient numbers and the lack of established mechanisms. We sought to investigate the prognostic impacts on patients with HCC of different gross subtypes and assess their corresponding molecular landscapes.
538. Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial.
作者: Xinrong Zhang.;Terry Cheuk-Fung Yip.;Grace Lai-Hung Wong.;Wei-Xuan Leow.;Lilian Yan Liang.;Lee-Ling Lim.;Guanlin Li.;Luqman Ibrahim.;Huapeng Lin.;Jimmy Che To Lai.;Angel Mei-Ling Chim.;Henry Lik Yuen Chan.;Alice Pik-Shan Kong.;Wah Kheong Chan.;Vincent Wai-Sun Wong.
来源: Gut. 2023年72卷12期2364-2371页
We aimed to test the hypothesis that automated fibrosis score calculation and electronic reminder messages could increase the detection of advanced liver disease in patients with type 2 diabetes.
539. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-κB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
作者: Xiaomeng Liu.;Rong Tang.;Jin Xu.;Zhen Tan.;Chen Liang.;Qingcai Meng.;Yubin Lei.;Jie Hua.;Yiyin Zhang.;Jiang Liu.;Bo Zhang.;Wei Wang.;Xianjun Yu.;Si Shi.
来源: Gut. 2023年72卷12期2329-2343页
Pancreatic ductal adenocarcinoma (PDAC) is among the most immunosuppressive tumour types. The tumour immune microenvironment (TIME) is largely driven by interactions between immune cells and heterogeneous tumour cells. Here, we aimed to investigate the mechanism of tumour cells in TIME formation and provide potential combination treatment strategies for PDAC patients based on genotypic heterogeneity.
540. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cells.
作者: Frances Winkler.;Anna V Hipp.;Carlos Ramirez.;Bianca Martin.;Matteo Villa.;Emilia Neuwirt.;Oliver Gorka.;Jeroen Aerssens.;Susanne E Johansson.;Nisha Rana.;Sian Llewellyn-Lacey.;David A Price.;Marcus Panning.;Olaf Groß.;Erika L Pearce.;Carl M Hermann.;Kathrin Schumann.;Luciana Hannibal.;Christoph Neumann-Haefelin.;Tobias Boettler.;Percy Knolle.;Maike Hofmann.;Dirk Wohlleber.;Robert Thimme.;Bertram Bengsch.
来源: Gut. 2023年72卷10期1971-1984页
Exhausted T cells with limited effector function are enriched in chronic hepatitis B and C virus (HBV and HCV) infection. Metabolic regulation contributes to exhaustion, but it remains unclear how metabolism relates to different exhaustion states, is impacted by antiviral therapy, and if metabolic checkpoints regulate dysfunction.
|